Silverarc Capital Management Llc

Top Portfolio
Top Buys
Top Sells
New Buys
Exits
Evogene Ltd.
EVGN
$2.31M6.13.09M-0.47%-$10,872.750.68
Poseida Therapeutics, Inc.
PSTX
$11.47M3.713.6M-2.95%-$348,676.563.38
Solid Biosciences Inc.
SLDB
$17.65M3.451.33M+122.75%+$9.73M5.2
TELA Bio, Inc.
TELA
$4.4M3.15776,851-2.29%-$103,358.431.3
Modular Medical, Inc.
MODD
$1.67M2.9900,000New+$1.67M0.49
Gossamer Bio, Inc.
GOSS
$7.23M2.716.13M0%+$02.13
Mersana Therapeutics, Inc.
MRSN
$13.3M2.432.97M-53.76%-$15.46M3.92
Kodiak Sciences Inc.
KOD
$6.52M2.361.24M+23.88%+$1.26M1.92
Helix Acquisition Corp. II Class A Ordinary Shares
HLXB
$5.2M2.17500,000New+$5.2M1.53
C4 Therapeutics, Inc.
CCCC
$11.73M2.091.44MNew+$11.73M3.45
ORIC Pharmaceuticals, Inc.
ORIC
$15.3M1.651.11M-4.87%-$783,653.744.51
UroGen Pharma Ltd.
URGN
$7.63M1.41508,587-3.2%-$252,255.002.25
Verona Pharma plc
VRNA
$2.2M1.35136,714New+$2.2M0.65
KalVista Pharmaceuticals, Inc.
KALV
$6.66M1.33561,183+402.25%+$5.33M1.96
Perspective Therapeutics, Inc.
CATX
$9.65M1.278.11MNew+$9.65M2.84
Trevi Therapeutics, Inc.
TRVI
$2.91M1.2844,235-2.27%-$67,785.610.86
Compugen Ltd.
CGEN
$2.58M1.121M+6.38%+$154,800.000.76
Praxis Precision Medicines, Inc.
PRAX
$11.63M1.11190,556-32.87%-$5.69M3.42
Cogent Biosciences, Inc.
COGT
$6.97M1.081.04M+7.23%+$469,855.662.05
Morphic Holding, Inc.
MORF
$17.04M0.97483,972-3.21%-$565,663.995.02
Merus N.V.
MRUS
$25.5M0.97566,287-12.28%-$3.57M7.51
Olema Pharmaceuticals, Inc.
OLMA
$5.83M0.92515,317-10.2%-$662,367.111.72
Cerus Corporation
CERS
$2.77M0.791.47M-2.27%-$64,462.230.82
MacroGenics, Inc.
MGNX
$7.04M0.76478,079-62.02%-$11.49M2.07
Jasper Therapeutics, Inc.
JSPR
$3.23M0.73109,892New+$3.23M0.95
Fulcrum Therapeutics, Inc.
FULC
$3.76M0.64398,436New+$3.76M1.11
Akero Therapeutics, Inc.
AKRO
$10.1M0.58399,949+60.46%+$3.81M2.98
ADC Therapeutics SA
ADCT
$2.25M0.52501,222New+$2.25M0.66
Avidity Biosciences, Inc.
RNA
$12.49M0.51489,303New+$12.49M3.68
EyePoint Pharmaceuticals, Inc.
EYPT
$5.13M0.48247,968New+$5.13M1.51
Celldex Therapeutics, Inc.
CLDX
$12.56M0.45299,316+21.07%+$2.19M3.7
Wave Life Sciences Ltd.
WVE
$3.06M0.41495,471New+$3.06M0.9
Terns Pharmaceuticals, Inc.
TERN
$1.64M0.39250,551-51.54%-$1.75M0.48
Veracyte, Inc.
VCYT
$6.22M0.37280,773+13.34%+$732,388.041.83
Pliant Therapeutics, Inc.
PLRX
$2.73M0.3183,392-42.42%-$2.01M0.81
Rhythm Pharmaceuticals, Inc.
RYTM
$7.96M0.3183,776+5.47%+$412,848.242.35
Scholar Rock Holding Corporation
SRRK
$3.54M0.25199,415-26.14%-$1.25M1.04
Nuvalent, Inc.
NUVL
$11.85M0.24157,750-18.26%-$2.65M3.49
Mirum Pharmaceuticals, Inc.
MIRM
$1.99M0.1779,194-2%-$40,619.030.59
Crinetics Pharmaceuticals, Inc.
CRNX
$5.98M0.16127,835New+$5.98M1.76
Rocket Pharmaceuticals, Inc.
RCKT
$2.72M0.11101,002-73.61%-$7.59M0.8
Xenon Pharmaceuticals Inc.
XENE
$2.85M0.0966,090-59.5%-$4.18M0.84
Apogee Therapeutics, Inc.
APGE
$3.32M0.0950,000New+$3.32M0.98
Insmed Incorporated
INSM
$3.08M0.08113,616-26.94%-$1.14M0.91
Cytokinetics, Incorporated
CYTK
$3.51M0.0450,000New+$3.51M1.03
Krystal Biotech, Inc.
KRYS
$1.78M0.0410,000New+$1.78M0.52
Intra-Cellular Therapies, Inc.
ITCI
$2.41M0.0334,807-56.49%-$3.13M0.71
Viking Therapeutics, Inc.
VKTX
$1.64M0.0220,000New+$1.64M0.48
Biogen Inc.
BIIB
$4.18M0.0119,365-3.17%-$136,925.051.23
DexCom, Inc.
DXCM
$2.77M0.0120,000-35.48%-$1.53M0.82